BioCryst Pharmaceuticals, Inc. Common Stock BCRX
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-12T03:02:46.133Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:50:38.178653057Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:54:06.603416+00:00
BioCryst Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 8.17 | 56.4% | 8.6% | 7.05 | 76.0% | 9.1% |
| 30Δ | 7.94 | 56.8% | 6.5% | 7.15 | 73.6% | 8.3% |
| 35Δ | 7.82 | 70.0% | 6.5% | 7.26 | 71.2% | 7.4% |
| 40Δ | 7.70 | 83.2% | 6.4% | 7.36 | 68.8% | 6.6% |
| 45Δ | 7.57 | 96.4% | 6.3% | 7.46 | 66.4% | 5.7% |
| 50Δ | 7.45 | 109.6% | 6.2% | 7.56 | 64.0% | 4.9% |
| 55Δ | 7.32 | 122.9% | 6.1% | 7.67 | 61.6% | 4.1% |
| 60Δ | 7.20 | 136.1% | 6.1% | 7.77 | 59.2% | 3.2% |
| 65Δ | 7.07 | 149.3% | 6.0% | 7.87 | 56.8% | 2.4% |
| 70Δ | 6.92 | 151.9% | 5.5% | 7.97 | 54.4% | 1.5% |
| 75Δ | 6.75 | 140.1% | 4.5% | 8.27 | 65.3% | 1.2% |
| 80Δ | 6.57 | 128.3% | 3.5% | 8.64 | 80.8% | 1.1% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 8.17
- IV
- 56.4%
- B/E move
- 8.6%
- Pseudo strike
- 7.05
- IV
- 76.0%
- B/E move
- 9.1%
30Δ
- Pseudo strike
- 7.94
- IV
- 56.8%
- B/E move
- 6.5%
- Pseudo strike
- 7.15
- IV
- 73.6%
- B/E move
- 8.3%
35Δ
- Pseudo strike
- 7.82
- IV
- 70.0%
- B/E move
- 6.5%
- Pseudo strike
- 7.26
- IV
- 71.2%
- B/E move
- 7.4%
40Δ
- Pseudo strike
- 7.70
- IV
- 83.2%
- B/E move
- 6.4%
- Pseudo strike
- 7.36
- IV
- 68.8%
- B/E move
- 6.6%
45Δ
- Pseudo strike
- 7.57
- IV
- 96.4%
- B/E move
- 6.3%
- Pseudo strike
- 7.46
- IV
- 66.4%
- B/E move
- 5.7%
50Δ
- Pseudo strike
- 7.45
- IV
- 109.6%
- B/E move
- 6.2%
- Pseudo strike
- 7.56
- IV
- 64.0%
- B/E move
- 4.9%
55Δ
- Pseudo strike
- 7.32
- IV
- 122.9%
- B/E move
- 6.1%
- Pseudo strike
- 7.67
- IV
- 61.6%
- B/E move
- 4.1%
60Δ
- Pseudo strike
- 7.20
- IV
- 136.1%
- B/E move
- 6.1%
- Pseudo strike
- 7.77
- IV
- 59.2%
- B/E move
- 3.2%
65Δ
- Pseudo strike
- 7.07
- IV
- 149.3%
- B/E move
- 6.0%
- Pseudo strike
- 7.87
- IV
- 56.8%
- B/E move
- 2.4%
70Δ
- Pseudo strike
- 6.92
- IV
- 151.9%
- B/E move
- 5.5%
- Pseudo strike
- 7.97
- IV
- 54.4%
- B/E move
- 1.5%
75Δ
- Pseudo strike
- 6.75
- IV
- 140.1%
- B/E move
- 4.5%
- Pseudo strike
- 8.27
- IV
- 65.3%
- B/E move
- 1.2%
80Δ
- Pseudo strike
- 6.57
- IV
- 128.3%
- B/E move
- 3.5%
- Pseudo strike
- 8.64
- IV
- 80.8%
- B/E move
- 1.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 77.73% | |
| 61.99% | |
| 63.71% | |
| 69.01% | |
| 57.39% | |
| 54.28% | |
| 73.25% | |
| 82.27% | |
| 56.34% | |
| 57.27% |
Drug Manufacturers - Specialty & Generic
BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The…
More →CGC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the…
More →COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
More →CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care,…
More →CRDL
Description unavailable
More →